Invenomic Capital Management’s Expedia Group EXPE Stock Holding History

Invenomic Capital Management’s Portfolio EXPE Stock Details EXPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-69,099	Closed	-$12.9M	–	178
2024 Q4	$12.9M	Sell	69,099 -119,152	-63%	-$20.5M	0.61%	47
2024 Q3	$27.9M	Sell	188,251 -65,260	-26%	-$8.65M	1.53%	17
2024 Q2	$31.9M	Buy	253,511 +73,411	+41%	+$9.05M	1.55%	14
2024 Q1	$24.8M	Buy	180,100 +21,199	+13%	+$3.01M	1.32%	24
2023 Q4	$24.1M	Sell	158,901 -239,669	-60%	-$29.3M	1.1%	25
2023 Q3	$41.1M	Buy	398,570 +75,136	+23%	+$8.29M	1.73%	18
2023 Q2	$35.4M	Buy	323,434 +87,028	+37%	+$8.53M	1.79%	15
2023 Q1	$22.9M	Buy	236,406 +116,543	+97%	+$12.2M	1.3%	27
2022 Q4	$10.5M	Buy	119,863 +58,295	+95%	+$5.51M	0.71%	48
2022 Q3	$5.77M	Buy	+61,568	New	+$6.28M	0.5%	66

Other funds holding EXPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPL

WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Invenomic Capital Management's EXPE Position: Q1 2025 in Review

Invenomic Capital Management sold out of Expedia Group (EXPE) in Q1 2025, closing a stake of 69,099 shares — an estimated $12.9M sold.

Invenomic Capital Management first reported a position in EXPE in Q3 2022 and held it in 10 quarters. The position peaked at $41.1M in Q3 2023. 906 funds tracked by Wall St. Rank hold EXPE as of Q1 2025.

Invenomic Capital Management reported no remaining Expedia Group position as of Q1 2025 after selling out during the quarter.
Invenomic Capital Management sold 69,099 Expedia Group shares in Q1 2025, an estimated $12.9M.
Invenomic Capital Management first reported a position in Expedia Group in Q3 2022 and held it in 10 quarters.
Invenomic Capital Management's Expedia Group position peaked at $41.1M in Q3 2023.
906 funds tracked by Wall St. Rank held Expedia Group as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.